Postmarket Registry for Evaluation of the Superion® Spacer

NCT04087811 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1674

Last updated 2023-07-06

Study results available
· View outcomes & findings →

Summary

To gather evidence documenting the performance and clinical outcomes associated with treatment of moderate degenerative lumbar spinal stenosis using the Superion® Indirect Decompression System (IDS).

Conditions

  • Lumbar Spinal Stenosis

Interventions

DEVICE

Superion® Indirect Decompression System (IDS)

Superion® Indirect Decompression System (IDS) (Superion® implant)

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Principal Investigators

  • Natalie Bloom Lyons · Boston Scientific Corporation

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-28
Primary Completion
2021-03-01
Completion
2021-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04087811 on ClinicalTrials.gov